In a filing, Maravai LifeSciences Holdings Inc revealed its Director GTCR INVESTMENT XI LLC unloaded Company’s shares for reported $97.57 million on May 28 ’24. In the deal valued at $9.81 per share,9,940,974 shares were sold. As a result of this transaction, GTCR INVESTMENT XI LLC now holds 20,150,005 shares worth roughly $175.31 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Craig Hallum initiated its Maravai LifeSciences Holdings Inc [MRVI] rating to a Buy in a research note published on April 10, 2024; the price target was $15. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in mid December from “a Neutral” to “a Buy”. KeyBanc Capital Markets also remained covering MRVI and has decreased its forecast on August 08, 2023 with a “Sector weight” recommendation from previously “an Overweight” rating. Credit Suisse revised its rating on May 23, 2023. It rated MRVI as “a Neutral” which previously was an “an Outperform”.
Price Performance Review of MRVI
On Monday, Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] saw its stock jump 1.87% to $8.70. Over the last five days, the stock has lost -5.33%. Maravai LifeSciences Holdings Inc shares have risen nearly 32.82% since the year began. Nevertheless, the stocks have fallen -15.53% over the past one year. While a 52-week high of $11.56 was reached on 05/17/24, a 52-week low of $4.52 was recorded on 02/22/24. SMA at 50 days reached $8.22, while 200 days put it at $7.40.
Levels Of Support And Resistance For MRVI Stock
The 24-hour chart illustrates a support level at 8.25, which if violated will result in even more drops to 7.79. On the upside, there is a resistance level at 9.14. A further resistance level may holdings at 9.57. The Relative Strength Index (RSI) on the 14-day chart is 49.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 51.15%. Stochastics%K at 43.91% indicates the stock is a holding.
How much short interest is there in Maravai LifeSciences Holdings Inc?
A steep rise in short interest was recorded in Maravai LifeSciences Holdings Inc stocks on
